1. Treatment of common coldBy
Dr.Mohamed Abd AlMoneim Attia

2. A. Nasal Decongestants
This group of drugs is used to treat the initial symptoms of irritation of the nasal mucosa (e.g. nasal Stuffiness, runny nose).
Agents that stimulate sympathetic responses or block parasympathetic responses are useful in treating nasal congestion.
Agents that block the action of histamine (Antihistaminics) are useful in preventing nasal discomfort caused by release of histamine in allergic disorders.

3. 1. Sympathomimetics
The sympathomimetics stimulate 1-adrenoceptor lead to vasoconstriction in the inflamed mucous membranes
Used for symptomatic relief
A. Systemically used :
Pseudoephedrine, Phenylpropanolamine Hcl
Its alpha stimulant action may raise blood pressure especially in patients given MAO inhibitors.
It has C.N.S stimulant action like amphetamine.

4. B. Topically used:
Imidazoline derivatives: oxymetazoline
The imidazoline compounds activate alpha adrenergic and imidazoline receptors and causes vasoconstriction.
Some imidazolines are administered by topical ocular or nasal administration to produce local decongestants, while others are administered by systemic routs.

5. Adverse reactions and precautions:
Topical application:
Burning and dryness of the mucosa which interfere with the ciliary action.
Rebound phenomena and tolerance: repeated and frequent use of topical decongestants can produce chronic swelling of the nasal mucosa similar to that of chronic rhinitis. (It is reversible on stopping the drug).
Chronic use may lead to atrophic rhinitis.
Systemic reactions when absorbed especially in infants and small children (tachycardia, palpitation, hypertension, arrhythmias).

6. Oral administration:
This route may produce systemic effects if larger doses are given, especially in infants and children or diseased patients.
Orally administered drugs may produce dangerous rise in blood pressure.

7. 2. Antihistamine There are three types of histamine receptors:
H1 receptors: present in different tissue mediate inflammation
H2 receptors: present in gastric parietal cells, heart and mast cells
H3 receptors: present at presynaptic sites-Nerve endings & Brain, inhibit the release of neurotransmitters.
H4 Highly expressed in bone morrow and white blood cells. Mediate mast cell chemotaxis.

8. Pharmacological Effects:
Extravascular smooth muscles:
Histamine increases permeability of blood vessels, which results in edema.
Cardiovascular system
Histamine decreases both systolic and diastolic blood pressure
Histamine produces positive inotropic and chronotropic effects

9. Exocrine glands
Histamine increase the release of gastric acid.
Histamine can also stimulate pancreatic, bronchiolar, lacrimal and salivary secretions. ( H1 receptors stimulation).
Nerve endings:
H1 stimulates various nerve ending causing pain and itching

10. Physiologic and Pathologic Roles
Gastric secretion
Allergic reactions and anaphylactic shock
Tissue repair and growth.
Therapeutic Uses
Histamine and its analogs have no well-established therapeutic uses, however it can be used in diagnoses of pernicious anemia and to test gastric acid secretion.

11. Antihistamine Physiological antagonists e.g. adrenaline
Blockers of histamine receptors:
H1 blockers (antihistamines)
H2 blockers. (antiulcer)
H3 blockers (still not approved for clinical use).
Histamine release inhibitors (mast cell stabilizers) e.g. ketotifen and cromoglycate.
Desensitization Therapy

12. Classification of antihistamines
Example (Trade name)
Group
1st generation
Diphenhydramine
Dimenhydrinate (Dramamine)
Clemastine
I- Ethanolamines
Antazoline
II-Ethylinediamines
Chlorpheniramine maleate
III-Alkylamines
Promethazine
IV- Phenothiazines
Cyclizine
Meclizine
V- Piperazines
Cyproheptadine
VI- Others
Loratidine
Terfenadine
2nd generation

13. Pharmacological Actions
The term antihistaminics still restricted to the drugs blocking H1 receptors.
Competitive block of H1 histaminic receptors and thus could prevent or reverse all effects of histamine produced by stimulation of H1 receptor at different tissues:
Smooth muscle of bronchi, small blood vessels and intestine.
Sensory impulses for itching.
Capillary endothelium.
Exocrine glands, except the stomach

14. CNS effects:
Sedation
Antiemetic effect (Decrease CRTZ).
Antimotion sickness (Decrease vestibular activity).
Muscarinic receptor blocking action (share in antimotion sickness activity).
Competitive block of other monoamine receptors e.g. Alpha adrenergic receptors. 5-HT receptors.
Block of sodium channel of excitable membrane (membrane stabilizing effect) e.g. Antazoline

15. Additional effects of the first generation
Anticholinergic effect → dry mouth, urinary retention, tachycardia
α- blocking effect →postural hypotension, reflex tachycardia.
Antiserotonin effect → ↑appetite

16. Therapeutic Uses
Prophylaxis and treatment of different allergic disorders
Treatment of vomiting of pregnancy e.g. cyclizine & promethazine.
Prophylaxis of motion sickness e.g. promethazine, dimenhydrinate and vertigo.
Treatment of carcinoid tumor (cyproheptadine)
Promotion of appetite (cyproheptadine)

17. The use of first generation H1 antihistamines is contraindicated in treatment of individuals working in jobs where wakefulness is critical

18. Differences between the old antihistaminics and the newer ones

19. 1st generation 2nd generation (non sedative group) Absent Present
Anticholinergic effects
Almost absent due to poor penetration to blood brain barrier
All of them have sedative effect with variable degrees
Sedative effect
Antiemetic effect
-blocking effect
Local anaesthetic effect
Most of them have long duration of action.
Short
Duration of action
1-Cardiac arrhythmias (prolong QT interval)
2-Interaction with enzyme inhibitors e.g. macrolid antibiotic and ketoconazol leading to lethal ventricular arrhythmia.
1-Sedation with impaired concentration
2-Atropine-like side effects
3- Postural hypotension
4-Drug allergy is relatively common.
Side effects